Abbott Laboratories 2012 Annual Report Download - page 18

Download and view the complete annual report

Please find page 18 of the 2012 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 68

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68

THIS IS
ABBVIE
BLENDING THE STABILITY,
GLOBAL SCALE, RESOURCES AND
COMMERCIAL CAPABILITIES OF
A PHARMACEUTICAL COMPANY
WITH THE FOCUS AND CULTURE
OF A BIOTECH, ABBVIE IS A UNIQUE
BIOPHARMACEUTICAL COMPANY.
AbbVie will build on a 125-year legacy
of success by leveraging a broad
product portfolio that includes a mix
of dierentiated growth brands and
sustainable performers. It has a strong
global footprint and a new-product
pipeline that includes a unique mix of
biologics and small molecules. And it
has an experienced management team
with a track record of outstanding
commercial execution.
Richard A. Gonzalez
Chairman and
Chief Executive Ocer of AbbVie
Abbott 2012 Annual Report
16